GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort NeuroScientific Corp (HKSE:02172) » Definitions » Cash Flow from Financing

MicroPort NeuroScientific (HKSE:02172) Cash Flow from Financing : HK$-241.9 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is MicroPort NeuroScientific Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Dec. 2024, MicroPort NeuroScientific paid HK$88.8 Mil more to buy back shares than it received from issuing new shares. It received HK$0.0 Mil from issuing more debt. It paid HK$0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received HK$0.0 Mil from paying cash dividends to shareholders. It spent HK$97.4 Mil on other financial activities. In all, MicroPort NeuroScientific spent HK$186.3 Mil on financial activities for the six months ended in Dec. 2024.


MicroPort NeuroScientific Cash Flow from Financing Historical Data

The historical data trend for MicroPort NeuroScientific's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort NeuroScientific Cash Flow from Financing Chart

MicroPort NeuroScientific Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Financing
Get a 7-Day Free Trial 511.97 245.81 368.00 -36.40 -241.57

MicroPort NeuroScientific Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only 292.18 -21.63 -14.77 -42.69 -199.23

MicroPort NeuroScientific Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

MicroPort NeuroScientific's Cash from Financing for the fiscal year that ended in Dec. 2024 is calculated as:

MicroPort NeuroScientific's Cash from Financing for the quarter that ended in Dec. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-241.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroPort NeuroScientific  (HKSE:02172) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

MicroPort NeuroScientific's issuance of stock for the six months ended in Dec. 2024 was HK$-88.8 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

MicroPort NeuroScientific's repurchase of stock for the six months ended in Dec. 2024 was HK$0.0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

MicroPort NeuroScientific's net issuance of debt for the six months ended in Dec. 2024 was HK$0.0 Mil. MicroPort NeuroScientific received HK$0.0 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

MicroPort NeuroScientific's net issuance of preferred for the six months ended in Dec. 2024 was HK$0.0 Mil. MicroPort NeuroScientific paid HK$0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

MicroPort NeuroScientific's cash flow for dividends for the six months ended in Dec. 2024 was HK$0.0 Mil. MicroPort NeuroScientific received HK$0.0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

MicroPort NeuroScientific's other financing for the six months ended in Dec. 2024 was HK$-97.4 Mil. MicroPort NeuroScientific spent HK$97.4 Mil on other financial activities.


MicroPort NeuroScientific Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of MicroPort NeuroScientific's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort NeuroScientific Business Description

Traded in Other Exchanges
N/A
Address
No. 1661 Zhangdong Road, Pudong New Area, Shanghai, CHN
MicroPort NeuroScientific Corp formerly MicroPort NeuroTech Ltd is into the neuro-interventional medical device industry, dedicated to providing solutions for physicians and patients. The company boast a comprehensive portfolio of approved therapeutic products covering all of the three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke.
Executives
Microport Scientific Corporation
Hu Yibin
Biolink Biomedical Ltd. 2201 Interest of corporation controlled by you
Blossom Vision Limited 2201 Interest of corporation controlled by you
Lion Fish Limited 2201 Interest of corporation controlled by you
Suntera Corporate Trustees (hong Kong) Limited 2301 Trustee
Thriving Hope Limited 2201 Interest of corporation controlled by you
Biolink Fund Limited Partnership 2201 Interest of corporation controlled by you
Biolink Limited 2101 Beneficial owner
Microport Scientific Investment Ltd
Maxwell Maxcare Science Foundation Limited
We'tron Capital Limited

MicroPort NeuroScientific Headlines

No Headlines